Faster Progression to Cannabis Use Disorder Does Not Directly Measure Tolerance
Faster progression from initial cannabis use to a use disorder or treatment is a clinical trajectory, not a direct measurement of pharmacological tolerance. A 2023 review treats the possible connection between these observations as a hypothesis needing controlled study.
What telescoping describes
Piscura and colleagues discuss reports that women may progress more quickly from initial cannabis use to cannabis use disorder or treatment despite greater lifetime use being reported among men. This accelerated course is often called telescoping.
The same section considers differences in escalation, withdrawal severity and treatment outcomes. These are clinically relevant observations, but they are not equivalent to repeatedly measuring a person’s response to a fixed THC exposure.
Why tolerance remains an interpretation
A direct tolerance comparison needs a defined response, an exposure history and an appropriate baseline. A shorter interval to treatment can be influenced by factors beyond adaptation to a drug’s physiological effects.
The review notes that human studies of sex differences in cannabinoid tolerance were limited and often retrospective. It also identifies fixed doses that are not adjusted for body weight as a complication when comparing responses between groups.
What a stronger study would clarify
Repeated assessments with controlled exposure could help distinguish initial sensitivity from changes that develop over time. Reporting subjective effects, cardiovascular responses and cognitive outcomes separately would avoid assuming they all adapt together.
The clinical trajectory should still be taken seriously on its own terms. The narrower scientific point is that an association with earlier disorder or treatment cannot quantify an individual’s THC tolerance or establish that tolerance caused that progression.
Related reading: A Human Tolerance Review Found Different Degrees of Adaptation Across Cognitive and Cardiac Outcomes.
Research cited
Piscura MK and colleagues. Mechanisms of Cannabinoid Tolerance (2023). This analysis draws on the review’s discussion of the cited experiments.
